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Abstract. Melittin is the main component of bee venom consisting of 26 amino acids that has multiple 
effects, including antibacterial, antiviral and anti-inflammatory in various cell types. This peptide 
forms pores in biological membranes and triggers cell death. Therefore it has potential as an anti-
cancer therapy. However, the therapeutic application of melittin is limited due to its main side effect, 
hemolysis, which is especially pronounced following intravenous administration. In the present study, 
we formulated tetrameric melittin-carrying poly-D,L-lactic-co-glycolic acid nanoparticles (PLGA-
NPs) and analyzed the lytic activity of this system on liposomes that resembles breast cancer cells. 
Tetrameric melittin binds avidly to PLGA-NPs with an encapsulation efficiency of 97% and retains its 
lytic activity demonstrating the effectiveness of PLGA-NPs as nanocarriers for this cytolytic peptide. 
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Introduction
Melittin is a naturally occurring cationic antimicrobial pep-
tide obtained from the toxic component in the venom of the 
European honey bee, Apis mellifera (Habermann 1977). It is 
a small linear peptide composed of 26 amino acids having 
the sequence NH2-GIGAVLKVLTTGLPALISWIKRKRQQ-
CONH2. The amino-terminal region (residues 1–20) of 
this peptide is predominantly hydrophobic whereas the 
carboxy-terminal region (residues 21–26) is hydrophilic 
due to the presence of a stretch of positively charged amino 
acids (Raghuraman and Chattopadhyay 2004a). Due to this 
amphiphilic property of melittin it becomes water-soluble 
and spontaneously associates with natural and artificial 
membranes (Raghuraman and Chattopadhyay 2004b). Be-
cause of poor cell selectivity, it exhibits strong lytic activity 
against both bacterial and mammalian cells (Raghuraman 
and Chattopadhyay 2007). Melittin is intrinsically fluorescent 
due to the presence of a single tryptophan residue at the 19th 
position. The presence of this tryptophan is utilized as the 
probe to study the interaction of the peptide with membranes 
and membrane-mimetic systems (Pott et al. 2001). Melittin’s 
action was thought to involve membrane pore formation or 
membrane perturbation, resulting in the disruption of the 
membrane (Allende et al. 2005; Yang et al. 2001; Shigeri et 
al. 2016). This peptide is an attractive anticancer candidate 
because of its wide-spectrum lytic properties. Although cy-
totoxic to a broad spectrum of tumor cells (Liu et al. 2008; 
Gajski et al. 2011; Jeong et al. 2014) melittin is also toxic 
to red blood cells and its therapeutic potential cannot be 
achieved without a proper delivery vehicle. This could be 
overcome by melittin nanoparticles that possess the ability 
374 Gonzalez-Horta et al.
to safely deliver a significant amount of melittin and to target 
and kill cancer cells. In recent years, nanoparticles (NPs) 
were prepared from biodegradable polymers such as poly-
D,L-lactic-co-glycolic acid (PLGA), a copolymer of lactic and 
glycolic acid approved by FDA for certain clinical uses. The 
polymer degradation time can vary from several months to 
years, depending on the molecular weight and copolymer 
ratio. PLGA is nontoxic, nonirritating and fully biodegrad-
able with good biocompatibility and human adaptability. In 
vivo, the final degradation product of PLGA is lactate that can 
be metabolized by intravital cells (Pan et al. 2011). Also, the 
physicochemical properties of bee venom-loaded PLGA-NPs 
has been characterized in order to design and optimize a suit-
able sustained release system (Bala et al. 2004), however, the 
melittin lytic activity on unilamellar lipid bilayer (liposomes) 
once incorporated into nanoparticles has not been evaluated. 
Liposomes are synthetic mimics of cellular membranes and 
represent an experimental system widely used for more than 
30 years in the field of biochemical research involving lipids. 
Another promising solution to reduce melittin´s cytotoxicity 
is to introduce cell selectivity by modulating melittin as-
sembly and its inherent secondary structure in the aqueous 
environment of the bloodstream (Park et al. 2015). In this 
study, we have performed spectroscopic studies aimed at 
disclosing the basic structural characteristics of tetrameric 
melittin after been incorporated into PLGA nanoparticles 
(PLGA-NPs).
Materials and Methods
Materials
Melittin (research grade) was purchased from Sigma Aldrich 
chemicals (Saint Louis, MO). The lipids L-a-phosphatidyl-
choline from egg yolk (PC), 1,2-diacyl-sn-glycero-3-phos-
phatidylethanolamine (PE), L-a-phosphatidic acid sodium 
salt (PA) and 1,2-diacyl-sn-glycero-3-phospho-L-serine (PS) 
were from Avanti polar lipids (Alabaster, AL). PLGA (MW 
50,000–75,000: lactide-co-glycolide ratio 85:15) was from 
Sigma Aldrich (Saint Louis, MO). ANTS (8-aminonaph-
thalene-1,3,6-trisulphonic acid) and DPX (N,N’-p-xylene-
bis-pyrimidinium bromide) were from Sigma Aldrich (Saint 
Louis, MO).
Methods
Melittin preparation
One milligram of melittin was dissolved in 1 ml buffer 
Hepes 20 mM pH 7.4 at 25°C to maintain the monomeric 
conformation. The tetrameric melittin conformation was 
obtained preparing peptide stock solution (final concentra-
tion 1.8 mM) in buffer 20 mM Hepes, 250 mM NaCl (pH 
7.4). To monitoring the a-helical content of melittin in solu-
tion under each experimental conditions, far-UV circular 
dichroism was recorder.
Nanoparticles preparation
Nanoparticles were prepared by double emulsion solvent 
evaporation method using power ultrasound. Double emul-
sion was prepared by two-step emulsification process. In the 
first step, in order to make the primary emulsion (W1/O), 
20  mg poly(lactic-co-glycolic acid) (PLGA, m.w. 17,000) 
were dissolved in 1.5 ml of ethyl acetate and 20 mg of Lu-
trol F 68 (Poloxamer 188, BASF) properly to form a clear 
solution. This mixture was homogenized properly using 
ultrasonic homogenizer for 90 s (Branson Ultrasonics Corp, 
Danbury, CT, USA). In the second step, the primary emul-
sion (W1/O) was dispersed in the outer aqueous phase (W2) 
containing magnesium chloride 3.0 % w/w. This mixture was 
homogenized via ultrasonic homogenizers for 90 s which 
produced double emulsion (W1/O/W2). Afterword, the 
organic solvent evaporation from dispersed droplets via 
rotary evaporator (Heidolph instruments GmbH and Co. 
Alemania) has led to solidified PLGA-NPs. Then 40 µl of 
an aqueous solution of tetrameric melittin (1.8 mM) was 
added to the preformed nanoparticles and the residual 
free (unbound) melittin washed out by centrifugation at 
35,000 rpm for 3 hours.
Hydrodynamic size measurement
The mean diameter and polydispersity index (PDI) of the 
nanoparticles were measured by dynamic light scattering 
(DLS) using a ZS90 (Malvern Instruments, R.U.) working 
at an angle of 90°. The analysis was performed right after the 
preparation of the nanoparticle dispersions. Before analysis, 
the samples were diluted 50 times in Milli-Q water to reach 
a level of light scattering signal recommended by the supplier 
of the light scattering apparatus. Each sample was analyzed 
in triplicate.
Determination of melittin assembled in nanoparticles 
Samples of nanoparticles loaded with melittin were ana-
lyzed by measuring the fluorescence intensity emitted by 
tryptophan 19 (excitation, 280 nm; emission, 351 nm) and 
interpolating the value on a calibration curve prepared for 
this purpose (y = 49.036x + 1.17; R2 = 0.9882). The calibra-
tion curve was obtained measuring the emission of melittin 
in buffer Hepes 20 mM (pH 7.4). The amount of melittin 
incorporated in nanoparticle was also confirmed by Bradford 
assay for which, the melittin-nanoparticles suspension were 
centrifuge at 10,000 rpm for 30 min to remove the unbound 
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melittin. The melittin in the supernatant was quantified as 
recommended by the manufacturer (Bio-Rad Protein Assay).
Circular dichroism
Conformational changes occurring once the peptide was 
assembled into nanoparticles were monitored by circular 
dichroism (CD) spectroscopy. CD spectra were registered in 
a J-1100 spectropolarimeter (JASCO, Easton, MD) equipped 
with a Koolance Peltier-type holder for temperature control 
at 25°C. All spectra were recorded in 0.2 nm wavelength 
increments with a 4 s response and a bandwidth of 1 nm. 
The secondary structure of the assembled and native melittin 
was assessed from spectra registered over the 190–240 nm 
(far-UV) at a scan rate of 50 nm/min. Each spectrum is the 
average of 5 scans with a full scale sensitivity of 50 mdeg. 
All spectra were corrected for background by subtraction 
of appropriate blanks and were smoothed making sure 
that the overall shape of the spectrum remains unaltered. 
Measurements were made in a 0.1 cm cuvette with melittin 
solutions (70 mM) or a diluted suspension of nanoparticles 
containing 100 mg of peptide per milliliter. The samples were 
equilibrated in buffer Hepes 5 mM pH 7.4. Helix content of 
peptides was assumed to be directly proportional to mean 
residue ellipticity (MRE) at 222 nm, [q]222. One hundred 
percent helicity was calculated using the formula max[q]222 
= –40,000 × [(1 – 2.5/h)] + (100 × T), where h is number of 
amino acid residues and T is temperature in °C (Scholtz et 
al. 1991; Jamasbi et al. 2014). Percentage helicity was then 
calculated as 100 × [q]222 /max[q]222.
Intrinsic fluorescence
The polarity of the microenvironment around tryptophan 
residue at position 19th was investigated by measuring the 
intrinsic fluorescence of melittin in buffer and melittin-
PLGA-NP after sample excitation with 280 nm UV radia-
tion. Emission spectra were registered from 300 to 500 nm 
in a LS45 spectrofluorometer (Perkin-Elmer Inc.) with 1 cm 
cells. Nanoparticle and melittin samples were prepared in 
buffer 20 mM Hepes, 150 mM NaCl (pH 7.4) and the protein 
concentration was adjusted to 15 µg/ml.
Vesicle preparation
We used the mixture PC/PE/PS (50:40:10 w/w) to simu-
late membranes healthy mammary epithelial cells and the 
mixture PC/PE/PS/PA (50:25:15:10 w/w) to resemble the 
membranes of breast cancer cells. As representative com-
pounds of erythrocyte membrane we used PC liposomes. 
The lipids were mixed in chloroform/methanol 2:1 (v/v) and 
the mixture was dried under a N2 stream and then for 2 h in 
a vacuum chamber to form a thin film which was later resus-
pended by addition of 1 ml of 50 mM Hepes buffer (pH 7.4), 
containing 150 mM NaCl and incubated for 2 h with eventual 
vortexing at 25°C for each lipid mixture. Large unilamellar 
vesicles (LUVs) were prepared using a Mini-extruder (Avanti 
Polar Lipids) with 10 mm diameter drain discs and 100 nm 
diameter Nuclepore Track-Etched membranes (Whatman) 
passing the multilamellar membrane vesicles suspension 11 
times through the filters at 25°C. 
Leakage of vesicle aqueous contents
Melittin-induce release of aqueous vesicle content was 
measured by using the ANTS/DPX assay. PC, PC/PE/PS 
(50:40:10 w/w) or PC/PE/PS/PA (50:25:15:10 w/w) vesicles 
were prepared by extrusion of lipid suspension prepared 
in 50 mM Hepes buffer, pH 7, containing 30 mM NaCl, 
12.5 mM of ANTS and 45 mM DPX as a quencher. Vesicles 
were separated from unencapsulated material on a Sephadex 
G-75 column (Sigma-Aldrich) by using 50 mM Hepes pH 7, 
containing 150 mM NaCl, as elution buffer. The final lipid 
concentration after exclusion chromatography was deter-
mined by phosphorus assay (Rouser et al. 1996). In a typical 
leakage assay, a given volume of melittin or melittin-PLGA-
NP was added from a concentrated solution to the ANTS/
DPX-loaded vesicles at 75 µM lipid. The resulting leakage 
was then followed by measuring the increase in fluorescence 
emission intensity at 536 nm, upon excitation at 353 nm, in 
a LS45 Perkin-Elmer spectrofluorometer. Complete (100%) 
release was achieved by the addition of 0.5% Triton X-100. 
All experiments were conducted at 25°C, and the apparent 
percentage of leakage was calculated according to the fol-
lowing equation: 
Leakage (%) = 100 × (F – Fo)/(Ft – Fo)
where F and Ft represent the fluorescence intensity before 
and after the addition of detergent, respectively, and Fo 
represents the fluorescence of intact vesicles.
Results and Discussion 
PLGA-NPs characterization 
Melittin was encapsulated in PLGA-NPs by the water-in-
oil-in-water (W1/O/W2) emulsion method optimized in our 
laboratory as previously described (Gonzalez et al. 2015). 
We characterized our PLGA-NP by undertaking the analysis 
of nanoparticle size and evaluating the amount of melittin 
adsorb in the PLGA-NP surface. DLS data indicated that 
nanoparticle size was 85 ± 20 nm (n = 3) with a narrow size 
distribution (Figure 1A) while the PDI < 0.1 confirmed that 
the particle was a typical monodisperse system. It is interest-
ing to note that the incorporation of melittin in the PLGA-
NPs leads to a narrow size distribution (Figure 1B) and to 
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an increase of nanoparticle size of 110 ± 20 nm (n = 3) as 
a result of adsorption of melittin at the nanoparticle surface. 
Melittin basic amino acids (I20-K21-R22-K23-R24-Q25) are 
responsible for an electric interaction with the lutrol polar 
group present in nanoparticle, leading to a small increase 
in average particle size. Similar results had been observed 
by other authors using three kinds of polymers (Cui et al. 
2005). It is well established that free melittin monomer is 
essentially a random coil molecule, whereas it displays a high 
a-helix content when it is bound to membranes (Vogel and 
Jähnig 1986). Once establish the amount of melittin incor-
porated into nanoparticle surface, CD spectroscopy was 
performed to evaluate the secondary structure of melittin 
in the PLGA-NPs.
Determination of melittin in PLGA-NPs 
To characterize the properties of the peptide incorporated 
into nanoparticles it is necessary to precisely determine 
the protein content in nanoparticle suspension. Therefore, 
samples of nanoparticles (prepared as described in the Ex-
perimental section) were analyzed by two different methods: 
Bradford assay and direct determination of melittin incorpo-
rated in nanoparticles by analyzing the fluorescence intensity 
emitted by tryptophan  19 (excitation, 280 nm; emission, 
351 nm) and interpolating the value on a calibration curve 
prepared for this purpose (y = 49.036x + 1.17; R2 = 0.9882). 
As determined by the Bradford assay, the protein content 
in nanoparticle was 175 ± 2 mg and as determined by fluo-
rescence intensity method, the amount of melittin incorpo-
rated was 170 ± 0.5 mg of the final nanoparticle suspension 
(average of three individual batches of nanoparticles). The 
percentage yield of melittin PLGA-NP was found to be 85%. 
Similar yields have been reported by Cui et al. (2005) for the 
preparation of PLGA-NPs by the double emulsion method. 
The mass ratio for vehicle: active was calculated and found 
that for every 40 mg of total solids (polymer and surfactant) 
is feasible to incorporate 170 mg of peptide. These values are 
consistent with those reported by other authors, which had 
evaluated the ability of interaction between PLGA particles 
and peptides or proteins and have shown a high interaction 
(Arroyo-Maya et al. 2014). However, it should be noted that 
the emission spectrum of melittin loaded PLGA-NP (Fig-
ure 2) appears to be blue-shifted (change in emission from 
351 nm to 331 nm) and more intense when compared with 
the spectrum of melittin in solution; these differences in fluo-
rescence properties are indicative of changes in the environ-
ment of aromatic residues that occur during the adsorption 
process. Specifically, the aforementioned spectral blue shift 
suggests that tryptophan (Trp) residue at position 19 is less 
exposed to the aqueous solvent in nanoparticle than native 
melittin. Similar results were observed for a-lactoalbumin 
when assembled into nanoparticles (Raghuraman et al. 2006). 
In the melittin tetramer, the intrinsic solvation probe of Trp 
is located at the junction between 2 a-helical monomers 
and is partially buried. However, Trp is fully exposed to the 
Figure 1. Mean size distribution of PLGA-
NPs (A) and melittin-PLGA-NPs (B). The 
analysis was performed right after the 
preparation of the nanoparticle dispersions. 
The samples were diluted 50 times in Milli-Q 
water to reach a level of light scattering signal 
recommended by the supplier of the light 
scattering apparatus. 
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solvent environment in the helical monomer. Raghuraman et 
al. reported that melittin tetramer is stabilized by increasing 
concentration of NaCl. The effect of NaCl on increasing the 
amount of tetramer starts around 0.25 M and the effect ap-
pears mainly for pH values less than 8 (Wilcox and Eisenberg 
1992) so, at the conditions used in this work, the tetrameric 
structure was form before addition to nanoparticles, and 
remains stable after the addition to nanoparticle. To confirm 
this, it was monitored the a-helical content in PLGA-NP 
loaded with melittin by circular dichroism at 222 nm. 
Conformational changes in melittin upon adsorption to 
nanoparticles
CD experiment (Figure 3) provides the idea about the sec-
ondary structure of monomeric and tetrameric melittin. 
Monomeric melittin shows a minimum at 205 nm, indicat-
ing the absence of any significant secondary structure in the 
peptide. The far UV spectrum of tetrameric melittin displays 
strength a-helical configuration with a broad negative band 
centered on 222 nm. It is well establish that increasing con-
centration of peptide and NaCl stabilizes melittin tetramer, 
so the stock solution prepared in this work agrees with these 
two conditions allowing melittin self-aggregation. Similar 
spectra were obtained by other authors in buffer 20 mM Tris, 
150 mM NaCl (pH 7.4) at 25°C and peptide concentration 
of 0.5 mM (Goto and Hagihara 1992; Liao et al. 2015). By 
increasing peptide and NaCl concentration the conformation 
of melittin changes from a mainly random-coiled structure, 
with only 21% of a-helix, to a mainly helical one with 56%. 
Our observation is in line with the experimentally measured 
helicity obtained by other authors (Takahashi et al. 2013).
We compared the CD spectra of tetrameric melittin 
once incorporated in PLGA-NP to determine whether 
similar changes in the secondary structure of melittin oc-
curred upon binding to the nanoparticles. Because control 
of PLGA-NP sample gave a flat ellipticity trace (see open 
circles in Figure  4), the CD band observed in melittin 
PLGA-NP can be attributed to the peptide present therein. 
The overall characteristics (i.e., peak position and ellipticity 
magnitude) of the spectrum clearly reflects the large num-
ber of a-helix regions found in this macromolecule, with 
double negative peaks at 222 nm and 208 nm and an helical 
content of 40%. Interestingly, the secondary structure of 
melittin PLGA-NP is similar to that reported as the CD 
spectra of tetrameric melittin at 0.5 mM peptide concen-
tration, suggesting that tetramer formation remains stable 
after incorporation of peptide to nanoparticle. These results 
confirm that melittin interacts with the PLGA-NP and ex-
ists as a stably integrated component of the nanoparticle 
in its tetrameric form even in the absence of a monolayer 
membrane surrounding the nanoparticle. Using a hybrid 
melittin cytolytic peptide (Huang et al. 2013) and a different 
nanoparticle composition (Soman et al. 2008) other authors 
obtained similar results. We then assessed the functional 
activity of melittin bound to nanoparticles by determin-
Figure 2. Fluorescence emission spectra of PLGA-NPs loaded with 
melittin. Intrinsic tryptophan fluorescence of melittin in solution 
(), fluorescence of melittin-PLGA-NPs () and polymeric nano-
particles () are shown. The excitation wavelength (λ) was 280 nm 
and the final peptide concentration was 20 mg/ml.
Figure 3. Circular dichroism (CD) spectra of monomeric () and 
tetrameric melittin (). The peptide concentration used for the CD 
analysis was 70 mM. Data are reported as mean residue ellipticity. 
Monomeric and tetrameric melittin was prepared as described in 
Materials and Methods.
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ing pore formation upon interaction with liposomes that 
resembles breast cancer cell.
Kinetics of liposome leakage 
Vesicles with different structures are used extensively in 
drug delivery and combinatory chemotherapeutic systems 
and can also be used to study artificial cell formation, 
which primitively mimics the membrane-based struc-
ture of eukaryotic cells (Paleos et al. 2012). Alterations 
of phospholipid profiles have been associated to disease 
and specific lipids may be involved in the onset and evo-
lution of cancer. Doria et al. (2013) reported a lipidomic 
analysis of phospholipids from human mammary epithelial 
cells and breast cancer cell lines (MCF10A, T47-D and 
MDA-MB-231) using off-line thin layer chromatogra-
phy (TLC) validated by hydrophilic interaction liquid 
chromatography-mass spectrometry. Differences in PE 
and PS content relative to total amount of phospholipids 
was highest in non-malignant cells while PA was present 
with highest relative abundant in metastatic cells (Doria et 
al. 2013). The phospholipids mixture used in this work for 
preparing liposomes where PC/PE/PS (50:40:10 w/w) to 
mimic membranes healthy mammary epithelial cells and 
the mixture PC/PE/PS/PA (50:25:15:10 w/w) to resemble 
the membranes of breast cancer cells. As representative 
compound of erythrocyte membrane, we used vesicles 
containing 100% PC. Membrane disruption by melittin 
PLGA-NP was characterized using a dye efflux assay. The 
assay is based on measuring the increase fluorescence that 
results from leakage of a quenched dye that is loaded into 
liposomes. The quenching property of fluorescence dye 
permits leakage from liposomes to be monitored continu-
ously and is sensitive to small perturbation in the bilayer 
(Ralston et al. 1981). LUVs were filled with ANTS/DPX at 
concentration at which ANTS fluorescence is quenched by 
DPX. Upon leakage from the vesicle, quenching of the dye 
is relieved and a fluorescence signal is observed. PLGA-NP 
loaded with melittin induces leakage of the aqueous content 
Figure 4. Circular dichroism spectra of free PLGA-NPs () and 
diluted suspension of tetrameric melittin-PLGA-NPs containing 
100 mg of protein per milliliter (). The samples were equilibrated 
in buffer Hepes 5mM pH 7.4. Data are reported as mean residue 
ellipticity.
Figure 5. ANTS/DPX release induced by PLGA-nanoparticles loaded with melittin from PC/PE/PS/PA (50:25:15:10 w/w) vesicles (A); 
PC/PE/PS (50:40:10 w/w) liposomes (B) and PC vesicles (C). Peptide concentration assayed were 1.5, 2.5, 3, 5, 7, 10 and 14 mM. The 
final lipid concentration was 75 mM. Peptide-induced liberation of the fluorophores ANTS from the vesicles was followed by monitoring 
fluorescence emission using excitation and emission wavelengths of 353 and 536 nm, respectively. The percentage of leakage induced 
by any given peptide concentration was estimated taking as a reference the maximum possible leakage, obtained after addition to the 
samples of an aliquot of Triton X-100 (final concentration of 0.5%, v/v). 
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from each kind of LUVs tested. The effect of phospholipid 
composition on the lytic power of melittin-PLGA-NP is 
shown in Figure 5. Initially, no fluorescence is observed 
in all cases since the high concentration (45 mM) of DPX 
used resulted in quenching of ANTS fluorescence. Upon 
addition of melittin-PLGA-NP, the entrapped ANTS/DPX 
were released into the buffer due to membrane perturba-
tion, leading to the dilution of the DPX quenching effect, 
increasing ANTS fluorescence. The extent of increase in 
fluorescence intensity is a measure of the lytic power of 
melittin in a given membrane environment. As is evident 
from the figure the lytic efficiency of nanoparticle-melittin 
in different vesicles is clearly dependent on the composition 
of the membrane: slightly higher lytic activity is observed 
in the presence of PA at any peptide concentration an also, 
the membrane perturbation effect occurs immediately 
after being added the peptide (Figure 5A). In the case of 
liposomes that resembles healthy mammary epithelial cells 
(PC/PE/PS 50:40:10 w/w) it can be observed that with 
the last three peptide concentrations evaluated, achieve 
the maximum lytic activity takes a  few seconds before 
fluorescence intensity reaches a plateau indicating that no 
further release occurs after a certain period (Figure 5B). 
For liposomes that resemble erythrocyte membrane (PC 
vesicles), the natural target of melittin, the kinetics also 
show that achieve the maximum lytic activity takes a few 
seconds before fluorescence intensity reaches a  plateau. 
It can be observed how from 10 mM peptide concentra-
tion takes longer to disrupt the lipid bilayer (Figure 5C). 
In all liposomes used in this work, the time required for 
melittin-PLGA-NP to produce maximum leakage, as well 
as the maximal amount o fluorescence liberated were both 
dependent on peptide concentration. 
The lipid disruption properties of melittin-PLGA-NP 
are summarized in Figure 6; it can be observed how the 
incorporation of melittin to PLGA-NP do not alter the 
cytolytic ability of this peptide on any of the phospholipid 
vesicles analyzed. Melittin-PLGA-NP were able to disrupt 
50% of the PC LUVs at concentrations of around 2 mM. The 
nanoparticles loaded with tetrameric melittin were more 
effective inducing leakage from PC/PE/PS (50:40:10 w/w) 
and PC/PE/PS/PA (50:25:15:10 w/w) at around 1.2 mM and 
1.8 mM, respectively. 
It has been reported that under similar experimental 
conditions, free melittin originate leakage from zwitterionic 
liposomes at around 0.25 mM and at 0.4 mM from liposomes 
containing 10% molar of negatively charged phospholipids 
(Higashino et al. 2001; Van den Bogaart et al. 2008; Soman et 
al. 2009) which represents an increase of about 8% in peptide 
concentration comparing with our results for zwitterionic 
liposomes and an increase of 3% for liposomes contain-
ing PS and 5% of liposomes with PA; so the tetrameric 
conformation of melittin incorporated in PLGA-NPs form 
a hydrophobic patch when a helical region is structured, 
reducing the lytic activity from zwitterionic lipids while 
retains its cytotoxic activity against anionic membranes. 
These results are in accordance with observations made by 
Pandey et al. (2010) who reported increasing cell selectiv-
ity using a Leu9Ala mutation which exhibited significantly 
reduce hemolytic activity than that of native melittin, while 
the analogues of melittin showed comparable antibacterial 
activities to melittin against Gram-positive and -negative 
bacteria (Pandey et al. 2010).
It is important to note that the lytic activity of our te-
trameric melittin-PLGA-NP is more cytotoxic than other 
melittin-nanoparticle system reported. Huang et al. (2013) 
designed a hybrid cytolytic peptide, a-melittin in which the 
N-terminus of melittin is linked to the C-terminus of an 
amphipathic a-helical peptide via a GSG linker. These a-
melittin-nanoparticles induced minimal hemoglobin release 
at concentration of 50 mM while the cytotoxicity in tumor 
cells was reached at 11.26 mM. This represents a tolerance 
of about 10 times more than our system for PC membranes 
Figure 6. Effect of melittin-PLGA-NPs on the leakage from PC 
(), PC/PE/PS (50:40:10 p/p) () and PC/PE/PS/PA (50:25:15:10 
w/w) () large unilamellar vesicles. Peptide concentration assay 
were 0.6, 0.8, 1.2, 1.8, 2.4, 3.6, 4.8 mM and the final lipid concen-
tration was 25 mM. Peptide-induced liberation of the fluorophore 
ANTS from the vesicles was followed by monitoring fluorescence 
emission using excitation and emission wavelengths of 353 nm 
and 536 nm, respectively. The percentage of leakage induced by 
any given peptide concentration was estimated taking as a refer-
ence the maximum possible leakage obtained after addition to the 
samples of an aliquot of Triton X-100 (final concentration 0.5% 
v/v). The typical error from at least two independent experiment 
is indicated.
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and around 2 times more for membranes containing anionic 
phospholipids. Soman et al. (2009) observed a more protec-
tive action against red blood cell hemolysis with the use of 
lipid-based melittin-perfluorocarbon nanoparticles; they 
report that even a  concentration of 25 mM nanoparticle-
melittin only elicited 10% hemolysis. So it is clear that to 
reduce melittin hemolytic activity is necessary to shield its 
hydrophobic N-terminal segment either through structural 
changes or alteration in melittin sequence or by conjugation 
with other hydrophobic molecules. In this light, our results 
demonstrated that is therefore possible to selectively favor 
melittin aggregation and preserve the complex peptide 
structure in an active form once incorporated to PLGA-
NP. However, we need to improve our formulation system 
to reduce even more melittin lytic activity on membrane 
model systems that aims to conduct hemolytic assays using 
red blood cells.
Conclusion
To summarize, our goal in this study was to formulate stable 
high payload PLGA particles as nanovehicles for tetrameric 
melittin and evaluate its utility as a cancer chemotherapeu-
tic agent in a model bilayer membrane system. Our results 
indicate that melittin tetrameric conformation in PLGA-NP 
is able to slightly reduce the lytic activity of this peptide over 
mammalian cell membrane mimetic model membranes, 
supporting a  crucial role for hydrophobic region to per-
meabilize zwitterionic liposomes, although the reduction 
observed it is not enough for in vivo administration. It is 
to be mentioned that our nanoparticle-system induced 
significant and very similar leakage in the PC/PE/PS and 
PC/PE/PS/PA lipid vesicles, which indicate that tetrameric 
melittin conformation retain the ability to permeabilize the 
negatively charged lipid membranes. Additional research is 
needed to investigate the mechanisms by which tetrameric 
melittin-PLGA-NP interact and perturb lipid bilayers. We 
need to improve our nanoparticle formulation to reduce even 
more melittin lytic activity that aims to conduct hemolytic 
assays using red blood cells and also cell viability assays 
against endothelial and breast cancer cell lines to translate 
our findings into useful therapeutic potential. 
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